日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting IL-11R/EZH2 signaling axis as a therapeutic strategy for osteosarcoma lung metastases

以 IL-11R/EZH2 信号轴为靶点治疗骨肉瘤肺转移

Eswaran Devarajan, R Eric Davis, Hannah C Beird, Wei-Lien Wang, V Behrana Jensen, Arumugam Jayakumar, Cheuk Hong Leung, Heather Y Lin, Chia-Chin Wu, Stephanie A Ihezie, Jen-Wei Tsai, P Andrew Futreal, Valerae O Lewis

Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous Leukemia

靶向 Unc51 样自噬激活激酶 1 (ULK1) 可克服急性髓性白血病中的适应性耐药性

Seemana Bhattacharya, Sujan Piya, Huaxian Ma, Priyanka Sharma, Qi Zhang, Natalia Baran, Vivian R Ruvolo, Teresa McQueen, R Eric Davis, Rasoul Pourebrahim, Marina Konopleva, Hagop Kantarjian, Nicholas D P Cosford, Michael Andreeff, Gautam Borthakur

Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia

抑制线粒体复合物 I 可逆转 NOTCH1 驱动的 T 细胞急性淋巴细胞白血病代谢重编程

Natalia Baran ,Alessia Lodi ,Yogesh Dhungana ,Shelley Herbrich ,Meghan Collins ,Shannon Sweeney ,Renu Pandey ,Anna Skwarska ,Shraddha Patel ,Mathieu Tremblay ,Vinitha Mary Kuruvilla ,Antonio Cavazos ,Mecit Kaplan ,Marc O Warmoes ,Diogo Troggian Veiga ,Ken Furudate ,Shanti Rojas-Sutterin ,Andre Haman ,Yves Gareau ,Anne Marinier ,Helen Ma ,Karine Harutyunyan ,May Daher ,Luciana Melo Garcia ,Gheath Al-Atrash ,Sujan Piya ,Vivian Ruvolo ,Wentao Yang ,Sriram Saravanan Shanmugavelandy ,Ningping Feng ,Jason Gay ,Di Du ,Jun J Yang ,Fieke W Hoff ,Marcin Kaminski ,Katarzyna Tomczak ,R Eric Davis ,Daniel Herranz ,Adolfo Ferrando ,Elias J Jabbour ,M Emilia Di Francesco ,David T Teachey ,Terzah M Horton ,Steven Kornblau ,Katayoun Rezvani ,Guy Sauvageau ,Mihai Gagea ,Michael Andreeff ,Koichi Takahashi ,Joseph R Marszalek ,Philip L Lorenzi ,Jiyang Yu ,Stefano Tiziani ,Trang Hoang ,Marina Konopleva

Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALL

靶向 T-ALL 白血病起始细胞中的 NOTCH1-MYC-CD44 轴

Sujan Piya #, Yaling Yang #, Seemana Bhattacharya, Priyanka Sharma, Huaxian Ma, Hong Mu, Hua He, Vivian Ruvolo, Natalia Baran, R Eric Davis, Abhinav K Jain, Marina Konopleava, Hagop Kantarjian, Michael Andreeff, M James You, Gautam Borthakur

Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML

抑制翻译起始因子 eIF4a 可使热休克因子 1 (HSF1) 失活并在 AML 中发挥抗白血病活性

Yuki Nishida, Ran Zhao, Lauren E Heese, Hiroki Akiyama, Shreya Patel, Alex M Jaeger, Rodrigo O Jacamo, Kensuke Kojima, Man Chun John Ma, Vivian R Ruvolo, Dhruv Chachad, William Devine, Susan Lindquist, R Eric Davis, John A Porco Jr, Luke Whitesell, Michael Andreeff, Jo Ishizawa

Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype

黑色素瘤通过获得高代谢表型而发展出完全的免疫疗法耐药性

Ashvin R Jaiswal ,Arthur J Liu # ,Shivanand Pudakalakatti # ,Prasanta Dutta ,Priyamvada Jayaprakash ,Todd Bartkowiak ,Casey R Ager ,Zhi-Qiang Wang ,Alexandre Reuben ,Zachary A Cooper ,Cristina Ivan ,Zhenlin Ju ,Felix Nwajei ,Jing Wang ,Michael A Davies ,R Eric Davis ,Jennifer A Wargo ,Pratip K Bhattacharya ,David S Hong ,Michael A Curran

Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality

线粒体 ClpP 介导的蛋白水解诱导选择性癌细胞致死

Jo Ishizawa, Sarah F Zarabi, R Eric Davis, Ondrej Halgas, Takenobu Nii, Yulia Jitkova, Ran Zhao, Jonathan St-Germain, Lauren E Heese, Grace Egan, Vivian R Ruvolo, Samir H Barghout, Yuki Nishida, Rose Hurren, Wencai Ma, Marcela Gronda, Todd Link, Keith Wong, Mark Mabanglo, Kensuke Kojima, Gautam Bort

FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation

FGL2 通过抑制 CD103+ 树突状细胞分化促进中枢神经系统肿瘤进展

Jun Yan, Qingnan Zhao, Konrad Gabrusiewicz, Ling-Yuan Kong, Xueqing Xia, Jian Wang, Martina Ott, Jingda Xu, R Eric Davis, Longfei Huo, Ganesh Rao, Shao-Cong Sun, Stephanie S Watowich, Amy B Heimberger, Shulin Li

BETP degradation simultaneously targets acute myelogenous leukemia stem cells and the microenvironment

BETP 降解同时作用于急性髓系白血病干细胞和微环境

Sujan Piya, Hong Mu, Seemana Bhattacharya, Philip L Lorenzi, R Eric Davis, Teresa McQueen, Vivian Ruvolo, Natalia Baran, Zhiqiang Wang, Yimin Qian, Craig M Crews, Marina Konopleva, Jo Ishizawa, M James You, Hagop Kantarjian, Michael Andreeff, Gautam Borthakur

Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy

肿瘤糖酵解增强是过继性T细胞疗法免疫抵抗的特征。

Tina Cascone ,Jodi A McKenzie ,Rina M Mbofung ,Simone Punt ,Zhe Wang ,Chunyu Xu ,Leila J Williams ,Zhiqiang Wang ,Christopher A Bristow ,Alessandro Carugo ,Michael D Peoples ,Lerong Li ,Tatiana Karpinets ,Lu Huang ,Shruti Malu ,Caitlin Creasy ,Sara E Leahey ,Jiong Chen ,Yuan Chen ,Helen Pelicano ,Chantale Bernatchez ,Y N Vashisht Gopal ,Timothy P Heffernan ,Jianhua Hu ,Jing Wang ,Rodabe N Amaria ,Levi A Garraway ,Peng Huang ,Peiying Yang ,Ignacio I Wistuba ,Scott E Woodman ,Jason Roszik ,R Eric Davis ,Michael A Davies ,John V Heymach ,Patrick Hwu ,Weiyi Peng